Development of environmentally biodegradable drugs: what are the key challenges?
Expert Opin Drug Discov
.
2024 Dec 24:1-4.
doi: 10.1080/17460441.2024.2442746.
Online ahead of print.
Authors
Michael G Bertram
1
2
3
,
Bob B M Wong
3
,
Klaus Kümmerer
4
5
,
Manuela Jörg
6
7
Affiliations
1
Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, Umeå, Sweden.
2
Department of Zoology, Stockholm University, Stockholm, Sweden.
3
School of Biological Sciences, Monash University, Melbourne, Australia.
4
Institute of Sustainable Chemistry, Leuphana University Lüneburg, Lüneburg, Germany.
5
International Sustainable Chemistry Collaborative Centre, Bonn, Germany.
6
Medicinal Chemistry Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
7
Centre for Cancer, Chemistry - School of Natural and Environmental Sciences, Newcastle University, Newcastle Upon Tyne, UK.
PMID:
39705026
DOI:
10.1080/17460441.2024.2442746
No abstract available
Keywords:
Benign by design; environment; green chemistry; pharmaceutical pollution; sustainability.
Publication types
Editorial